495 related articles for article (PubMed ID: 28958948)
21. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation.
Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB
Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
[TBL] [Abstract][Full Text] [Related]
23. Protective effects of sea buckthorn polysaccharide extracts against LPS/d-GalN-induced acute liver failure in mice via suppressing TLR4-NF-κB signaling.
Liu H; Zhang W; Dong S; Song L; Zhao S; Wu C; Wang X; Liu F; Xie J; Wang J; Wang Y
J Ethnopharmacol; 2015 Dec; 176():69-78. PubMed ID: 26494508
[TBL] [Abstract][Full Text] [Related]
24. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
[TBL] [Abstract][Full Text] [Related]
25. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H
Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756
[TBL] [Abstract][Full Text] [Related]
26. Protective effects of protostemonine on LPS/GalN-induced acute liver failure: Roles of increased hepatic expression of heme oxygenase-1.
Cheng Z; Yue L; Zhao W; Yang X; Shu G
Int Immunopharmacol; 2015 Dec; 29(2):798-807. PubMed ID: 26363973
[TBL] [Abstract][Full Text] [Related]
27. Ellagic acid protects Lipopolysaccharide/D-galactosamine-induced acute hepatic injury in mice.
Gu L; Deng WS; Liu Y; Jiang CH; Sun LC; Sun XF; Xu Q; Zhou H
Int Immunopharmacol; 2014 Oct; 22(2):341-5. PubMed ID: 25038320
[TBL] [Abstract][Full Text] [Related]
28. The polysaccharides from the
Meng M; Zhang R; Han R; Kong Y; Wang R; Hou L
Food Funct; 2021 Mar; 12(5):1973-1982. PubMed ID: 33586729
[TBL] [Abstract][Full Text] [Related]
29. Spiranthes sinensis Suppresses Production of Pro-Inflammatory Mediators by Down-Regulating the NF-κB Signaling Pathway and Up-Regulating HO-1/Nrf2 Anti-Oxidant Protein.
Shie PH; Huang SS; Deng JS; Huang GJ
Am J Chin Med; 2015; 43(5):969-89. PubMed ID: 26224027
[TBL] [Abstract][Full Text] [Related]
30. Mangiferin alleviates lipopolysaccharide and D-galactosamine-induced acute liver injury by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Pan CW; Pan ZZ; Hu JJ; Chen WL; Zhou GY; Lin W; Jin LX; Xu CL
Eur J Pharmacol; 2016 Jan; 770():85-91. PubMed ID: 26668000
[TBL] [Abstract][Full Text] [Related]
31. Saikosaponin a ameliorates lipopolysaccharide and d‑galactosamine-induced liver injury via activating LXRα.
Zhu Y; Chen X; Rao X; Zheng C; Peng X
Int Immunopharmacol; 2019 Jul; 72():131-137. PubMed ID: 30981078
[TBL] [Abstract][Full Text] [Related]
32. Amygdalin attenuates acute liver injury induced by D-galactosamine and lipopolysaccharide by regulating the NLRP3, NF-κB and Nrf2/NQO1 signalling pathways.
Tang F; Fan K; Wang K; Bian C
Biomed Pharmacother; 2019 Mar; 111():527-536. PubMed ID: 30597306
[TBL] [Abstract][Full Text] [Related]
33. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L
Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of oroxylin A against lipopolysaccharide and/or D-galactosamine-induced acute liver injury in mice.
Huang H; Zhang X; Li J
J Surg Res; 2015 May; 195(2):522-8. PubMed ID: 25818981
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of Gö6976, a PKD inhibitor, on LPS/D: -GalN-induced acute liver injury in mice.
Duan GJ; Zhu J; Xu CY; Wan JY; Zhang L; Ge XD; Liu LM; Liu YS
Inflamm Res; 2011 Apr; 60(4):357-66. PubMed ID: 21063746
[TBL] [Abstract][Full Text] [Related]
36. BML-111 Protected LPS/D-GalN-Induced Acute Liver Injury in Rats.
Yan D; Liu HL; Yu ZJ; Huang YH; Gao D; Hao H; Liao SS; Xu FY; Zhou XY
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420055
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats.
Choi JH; Kang JW; Kim DW; Sung YK; Lee SM
Eur J Pharmacol; 2011 Apr; 657(1-3):138-43. PubMed ID: 21284943
[TBL] [Abstract][Full Text] [Related]
38. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation.
Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X
Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915
[TBL] [Abstract][Full Text] [Related]
39. Tenuigenin inhibits LPS-induced inflammatory responses in microglia via activating the Nrf2-mediated HO-1 signaling pathway.
Wang X; Li M; Cao Y; Wang J; Zhang H; Zhou X; Li Q; Wang L
Eur J Pharmacol; 2017 Aug; 809():196-202. PubMed ID: 28478071
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
